3H-Cyclopenta[c]quinoline, 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-, (3aS,4R,9bR)-, 99%, 250mg

(5-FORMYL-2-METHOXYPHENYL)BORONIC ACID PINACOL ESTER, 95%, 25g

(2S,4S)-1-((S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 98%, 250mg

2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione, 97%, 5g

4-(Diphenylhydroxymethyl)benzoic acid, 98.0%, 1g

Methyl 2,4-dimethylbenzoate, 95.0%, 100g

Methyl 2-(3-hydroxycyclobutyl)acetate, 98%, 5g

1,1-DIMETHYL-3-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)UREA, 95%, 1g

4-Chloro-N-methylaniline>97.0%(GC)(T)5g

5-(difluoromethoxy)-1H-benzo[d]imidazol-2-ol  (Pantoprazole Impurity）, 98%, 5g

Propynol ethoxylate, min 98%, for synthesis, 1L, glass packaging

2-(Boc-amino)-4-cyanopyridine, 98%, 100mg

(3aR,5R,6S,7aS)-octahydro-1H-isoindole-5,6-diol hydrochloride, 95.0%, 250mg